Jaap AR Koot
Biographic Data
| ID | 9023524 |
|---|---|
| NAME | Jaap AR Koot |
| GIVEN NAMES | Jaap AR |
| FAMILY NAME | Koot |
| SIGNATURE | KOOT J A |
| AFFILIATIONS | University Medical Center Groningen |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Efficient high-risk human papillomavirus screening through pooled testing
Background: The World Health Organization recommends high-risk human papillomavirus (hrHPV) testing as the primary method for cervical cancer screening. Combining samples in a pool can reduce the expense associated with large numbers of commercially available tests. This study simulated the potential test-saving impact of pooled hrHPV testing using real-world data from two low- and middle-income countries (LMICs). Methods: We simulated a two- and…
Early evaluation of a screen-and-treat strategy using high-risk HPV testing for Uganda
Background: Uganda has a high burden of cervical cancer and its current coverage of screening based on visual inspection with acetic acid (VIA) is low. High-risk HPV (hrHPV) testing is recommended by the World Health Organization as part of the global elimination strategy for cervical cancer. In this context, country-specific health economic evaluations can inform national-level decisions regarding implementation. We evaluated the recommended hrH…
No prominent works on this page.
Early evaluation of a screen-and-treat strategy using high-risk HPV testing for Uganda
Background: Uganda has a high burden of cervical cancer and its current coverage of screening based on visual inspection with acetic acid (VIA) is low. High-risk HPV (hrHPV) testing is recommended by the World Health Organization as part of the global elimination strategy for cervical cancer. In this context, country-specific health economic evaluations can inform national-level decisions regarding implementation. We evaluated the recommended hrH…
Efficient high-risk human papillomavirus screening through pooled testing
Background: The World Health Organization recommends high-risk human papillomavirus (hrHPV) testing as the primary method for cervical cancer screening. Combining samples in a pool can reduce the expense associated with large numbers of commercially available tests. This study simulated the potential test-saving impact of pooled hrHPV testing using real-world data from two low- and middle-income countries (LMICs). Methods: We simulated a two- and…
Cervical Cancer and HPV Research (2 works) · Global Cancer Incidence and Screening (2 works) · Biology (1 work) · Cervical cancer (1 work) · Cervical cancer screening (1 work) · Cervical screening (1 work) · Head and Neck Cancer Studies (1 work) · Human papillomavirus (1 work) · Intensive care medicine (1 work) · Medical physics (1 work)